Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL

Zurko, J; Nizamuddin, I; Epperla, N; David, K; Cohen, JB; Moyo, TK; Ollila, T; Hess, B; Roy, I; Ferdman, R; Liu, JQ; Chowdhury, SM; Romancik, J; Bhansali, RS; Harris, EI; Sorrell, M; Masel, R; Kittai, AS; Denlinger, N; Sigmund, AM; Fitzgerald, L; Galvez, C; Ma, S; Winter, J; Pro, B; Gordon, LI; Danilov, A; Stephens, D; Shah, NN; Kenkre, V; Barta, SK; Torka, P; Shouse, G; Karmali, R

Karmali, R (通讯作者),Northwestern Univ, Comprehes Canc Ctr, Feinberg Sch Med, 676 N St Clair St,Suite 850, Chicago, IL 60611 USA.

BLOOD ADVANCES, 2023; 7 (12): 2657

Abstract

Most patients receiving chimeric antigen receptor T-cell therapy (CAR-T) for aggressive B-cell non-Hodgkin lymphoma (B-NHL) do not experience a durabl......

Full Text Link